How SCA Pharma is Meeting Operational Challenges During COVID-19 

‘SCA PHARMA RESPONDS TO COVID-19: A BLOG SERIES’

COVID-19 has transformed the delivery of health care in ways many of us could not have imagined. But as the crisis continues and evolves, it’s important to learn from early lessons COVID-19 has taught us.

In a series of blogs and videos, senior leaders at SCA Pharma address the pandemic’s impact on quality, operations, product demand, and overall customer service during these challenging times.

Matt White is General Manager of SCA Pharma’s Little Rock site and Vice President of Operations. He’s also a Doctor of Pharmacy. In the video below, Matt discusses the effects of the pandemic on our operations and workforce, and what SCA Pharma is doing to meet challenges head on. 

Click here to watch the video. 

You can download our updated list of medications to treat COVID-19 here.

To see all installments of this blog series, click here. 

SCA Pharma is an FDA 503B outsourcing facility providing the highest quality sterile admixtures and pre-filled syringes. SCA Pharma specializes in preparing sterile pharmaceuticals customized for hospital pharmacies and healthcare facilities nationwide. 

Headquartered in Little Rock, Arkansas, SCA Pharma has two state-of-the-art production facilities in both Arkansas and Connecticut.  For more information, contact marketing@scapharma.com.